The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•1 May 2026•

1 min read

Major Investment Banks Issue Mixed Price Target Adjustments for US Equities

Key Facts

1Argus reduced the price target for TMO to $560 from $610 following the sale of its microbiology business.

2Morgan Stanley adjusted the price target for BRO down to $65 from $70.

3BMO Capital increased the price target for XEL to $95 from $94 after Q1 earnings beat estimates.

Major financial institutions, including Morgan Stanley and Argus, have issued mixed price target revisions for several leading US equities. Argus reduced its price target for Thermo Fisher Scientific (TMO) to $560 from $610 following the divestiture of its microbiology business. Similarly, Morgan Stanley adjusted its target for Brown & Brown (BRO) downward to $65 from $70. Conversely, BMO Capital raised its price target for Xcel Energy (XEL) to $95 after the company’s first-quarter earnings surpassed market expectations. These adjustments reflect analyst responses to corporate restructuring and quarterly financial performance. Such revisions serve as critical indicators for investors monitoring mid and large-cap stock valuations in the current market environment.